BHST - רווח נקי למניה (EPS TTM) BioHarvest Sciences, Inc.

BioHarvest Sciences (BHST) holds patents for hydroponic extraction, creating an insurmountable barrier for competitors. The use of bioreactors ensures seamless scaling and high margins without land costs, while the company actively expands the application of its technologies from nutraceuticals to medicine. The annual earnings per share trend reflects the current trajectory, where the -0.53 mark serves as a key metric.

Management ambitions at BioHarvest Sciences (BHST) to scale its botanical synthesis platform require strict validation through operational efficiency. An analysis of the current trailing twelve-month net income per share, reflecting the ratio of bottom-line earnings to the number of securities, allows for an assessment of the business's real yield per share and determines the level of debt burden during the recovery of cash flows, which is critical for evaluating the asset's reliability.